CAMP4 Therapeutics Corporation (CAMP)
NASDAQ·Healthcare·Biotechnology
$4.35
-2.14%
Mkt Cap $94.31M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 5, 2026 | $475.20K | $348.00K | -26.77% | -$0.31 | -$0.87 | -180.65% | — | — |
| Q4 2025 Nov 6, 2025 | $433.33K | $795.00K | +83.46% | -$0.47 | -$0.55 | -17.02% | — | — |
| Q3 2025 Aug 14, 2025 | $128.00K | $1.50M | +1069.53% | -$0.67 | -$0.62 | +7.46% | — | — |
| Q2 2025 May 13, 2025 | $420.18K | $858.00K | +104.20% | -$0.70 | -$0.62 | +11.43% | — | — |
| Q1 2025 Mar 27, 2025 | $33.33K | $652.00K | +1856.20% | -$0.91 | -$2.83 | -210.99% | — | — |
| Q4 2024 Oct 11, 2024 | $250.00K | — | — | -$1.07 | -$0.69 | +35.59% | — | — |
| Q3 2024 Jul 8, 2024 | $51.27M | — | — | -$0.92 | -$1.61 | -75.00% | — | — |
| Q2 2024 Jun 6, 2024 | $51.27M | — | — | -$2.04 | -$1.03 | +49.66% | — | — |
| Q1 2024 Jan 9, 2024 | $51.27M | $53.63M | +4.59% | -$2.30 | -$3.91 | -70.00% | — | — |
| Q4 2023 Oct 5, 2023 | $56.20M | $61.71M | +9.81% | -$0.00 | -$0.01 | -133.10% | — | — |
| Q3 2023 Jul 10, 2023 | $70.35M | $70.89M | +0.77% | $0.92 | -$0.23 | -125.00% | — | — |
| Q2 2023 Apr 27, 2023 | $75.66M | $78.51M | +3.76% | $0.23 | $1.38 | +500.00% | — | — |
| Q2 2023 Apr 19, 2023 | — | $78.89M | — | $0.03 | -$0.13 | -533.93% | — | — |
| Q4 2022 Dec 20, 2022 | $75.29M | $72.83M | -3.27% | -$0.09 | -$0.06 | +33.33% | — | — |
| Q3 2022 Sep 22, 2022 | $69.27M | $64.73M | -6.57% | -$0.92 | -$0.46 | +50.00% | — | — |
| Q2 2022 Jun 23, 2022 | $69.43M | $68.38M | -1.52% | -$1.15 | -$2.30 | -100.00% | — | — |
| Q2 2022 Apr 28, 2022 | $68.44M | $68.78M | +0.50% | -$1.38 | -$0.23 | +83.33% | — | — |
| Q4 2021 Dec 21, 2021 | $68.60M | $79.01M | +15.18% | -$0.23 | -$1.84 | -700.00% | — | — |
| Q3 2021 Sep 23, 2021 | $177.77M | $79.67M | -55.18% | $1.38 | $1.84 | +33.33% | — | — |
| Q2 2021 Jun 24, 2021 | $80.25M | $81.95M | +2.11% | $1.61 | $1.84 | +14.29% | — | — |